Circulating tumor cells (CTCs) are cancer cells shredded from either a primary tumor or a
metastatic site and circulate in the blood as the potential cellular origin of metastasis. By …

The isolation and detection of circulating tumor cells (CTCs) play an important role in early
cancer diagnosis and prognosis, providing easy access to identify metastatic cells before …

The event of cancer metastasis, wherein tumor cells detach from the primary tumor site and
travel to distant tissue or organs through the circulatory system of the body, is currently …

Analysis of circulating tumor cells (CTCs) collected from patient's blood offers a broad range
of opportunities in the field of precision oncology. With new advances in profiling technology …

Microfluidic chip is not a chip in the traditional sense. It is technologies that control fluids at
the micro level. As a burgeoning biochip, microfluidic chips integrate multiple disciplines …

The availability of new therapeutic options for the treatment of metastatic castration-resistant
prostate cancer (mCRPC) has heightened the importance of monitoring and assessing …

Circulating tumor cells (CTCs) are established cancer biomarkers for the “liquid biopsy” of
tumors. Molecular analysis of single CTCs, which recapitulate primary and metastatic tumor …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the tumors with the
highest mortality, for which survival has hardly changed in the last 40 years. This high …

The poor prognosis of pancreatic cancer patients is associated with the frequent and early
dissemination of the disease, as well as late detection due to unspecific and late symptoms …

Circulating tumor cells (CTCs) are single cells or clusters of cells within the circulatory
system of a cancer patient. While most CTCs will perish, a small proportion will proceed to …